# Robert S. Mannel

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/robert-s-mannel/

## Facts

| Field | Value |
| --- | --- |
| Citations | 51,813 |
| Field | Ovarian cancer diagnosis and treatment |
| h-index | 83 |
| i10-index | 192 |
| Last Known Institution | Oklahoma State University Oklahoma City |
| OpenAlex ID | https://openalex.org/A5061736280 |
| Works | 391 |

## Researcher papers

- [Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer](https://scholariq.org/papers/incorporation-of-bevacizumab-in-the-primary-treatment-of-ovarian-cancer/)
- [Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study](https://scholariq.org/papers/phase-iii-trial-of-carboplatin-and-paclitaxel-compared-with-cisplatin-and/)
- [Inherited Mutations in Women With Ovarian Carcinoma](https://scholariq.org/papers/inherited-mutations-in-women-with-ovarian-carcinoma/)
- [Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer](https://scholariq.org/papers/pembrolizumab-plus-chemotherapy-in-advanced-endometrial-cancer/)
- [Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial](https://scholariq.org/papers/bevacizumab-and-paclitaxel-carboplatin-chemotherapy-and-secondary-cytoreduction/)
- [Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer](https://scholariq.org/papers/final-overall-survival-of-a-randomized-trial-of-bevacizumab-for-primary/)

## Researcher topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Intraperitoneal and Appendiceal Malignancies](https://scholariq.org/topics/intraperitoneal-and-appendiceal-malignancies/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)

## Researcher university

- [Oklahoma State University Oklahoma City](https://scholariq.org/institutions/oklahoma-state-university-oklahoma-city/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.